IMPACT FACTOR JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOGS LaTeX 5G Tutorial Advertise
 

Search About Journals, Conferences, and Book Series


Current Treatment Options in Oncology- Impact Factor, Overall Ranking, h-index, SJR, Rating, Publisher, ISSN, and Other Important Metrics

Last Updated on October 4, 2021

Impact Factor

5.036

h-Index

 53

Rank

 2379

SJR

 1.457

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics

Title Current Treatment Options in Oncology
Abbreviation Curr. Treat. Options Oncol.
Publication Type Journal
Subject Area, Categories, Scope Oncology (Q1); Pharmacology (medical) (Q1)
h-index 53
Overall Rank/Ranking 2379
SCImago Journal Rank (SJR) 1.457
Impact Score 4.66
Impact Factor 5.036 (2020)
Publisher Springer New York
Country United States
ISSN 15346277, 15272729


About Current Treatment Options in Oncology


Current Treatment Options in Oncology is a journal covering the technologies/fields/categories related to Oncology (Q1); Pharmacology (medical) (Q1). It is published by Springer New York. The overall rank of Current Treatment Options in Oncology is 2379. According to SCImago Journal Rank (SJR), this journal is ranked 1.457. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 53. The best quartile for this journal is Q1.

The ISSN of Current Treatment Options in Oncology journal is 15346277, 15272729. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Current Treatment Options in Oncology is cited by a total of 1137 articles during the last 3 years (Preceding 2020).


Current Treatment Options in Oncology Impact Factor 2020-2021


The impact factor (IF) 2020 of Current Treatment Options in Oncology is 5.036, which is computed in 2021 as per it's definition. Current Treatment Options in Oncology IF is increased by a factor of 1.14 and approximate percentage change is 29.13% when compared to preceding year 2019, which shows a rising trend. The impact factor (If), also denoted as Journal impact factor (JIF), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Web of Science data.

Table Setting

Impact Factor Trend


Year wise Impact Factor (IF) of Current Treatment Options in Oncology. Based on Web of Science data.


Year Impact Factor (IF)
2021/2022Coming Soon
2020 5.036
2019 3.900
2018 3.851
2017 3.562
2016 2.820
2015 2.127
2014 2.822
2013 3.240
2012 2.422
2011 2.684
2010 2.213

Current Treatment Options in Oncology Impact Score 2020-2021


The impact score (IS) 2020 of Current Treatment Options in Oncology is 4.66, which is computed in 2021 as per its definition. Current Treatment Options in Oncology IS is increased by a factor of 0.89 and approximate percentage change is 23.61% when compared to preceding year 2019, which shows a rising trend. The impact score (IS), also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Current Treatment Options in Oncology Impact Score 2021 Prediction


IS 2020 of Current Treatment Options in Oncology is 4.66. If the same upward trend persists, impact score of joule may rise in 2021 as well.


Impact Score Trend


Year wise Impact Score (IS) of Current Treatment Options in Oncology. Based on Scopus data.


Year Impact Score (IS)
2021/2022 Coming Soon
2020 4.66
2019 3.77
2018 4.06
2017 3.98
2016 3.33
2015 2.76
2014 3.59

Current Treatment Options in Oncology h-index


  Table Setting

Current Treatment Options in Oncology has an h-index of 53. It means 53 articles of this journal have more than 53 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Current Treatment Options in Oncology ISSN


The ISSN of Current Treatment Options in Oncology is 15346277, 15272729. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Current Treatment Options in Oncology Rank and SCImago Journal Rank (SJR)


The overall rank of Current Treatment Options in Oncology is 2379. According to SCImago Journal Rank (SJR), this journal is ranked 1.457. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


Current Treatment Options in Oncology Publisher


Table Setting

Current Treatment Options in Oncology is published by Springer New York. It's publishing house is located in United States. Coverage history of this journal is as following: 2000-2020. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Current Treatment Options in Oncology is Curr. Treat. Options Oncol.. This abbreviation ('Curr. Treat. Options Oncol.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Current Treatment Options in Oncology


If your research field is/are related to Oncology (Q1); Pharmacology (medical) (Q1), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Factor, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
SHAW journal 31763 Penn State University Press 3 0.00
Journal of Philosophical Research journal 19162 Philosophy Documentation Center 13 0.42
Progress In Electromagnetics Research C journal 13623 EMW Publishing 34 1.48
2017 3rd IEEE International Conference on Control Science and Systems Engineering, ICCSSE 2017 conference and proceedings 23866 6 0.00
Journal of Thoracic Disease journal 7329 Pioneer Bioscience Publishing Company (PBPC) 60 1.70
Transfusion Clinique et Biologique journal 13351 Elsevier Masson 39 1.18
WEFTEC 2019 - 92nd Annual Water Environment Federation's Technical Exhibition and Conference conference and proceedings 29331 2 0.14
Proceedings, Annual Conference - Canadian Society for Civil Engineering conference and proceedings 29286 13 0.12
2018 IEEE Colombian Conference on Communications and Computing, COLCOM 2018 - Proceedings conference and proceedings 22289 4 0.68
Zeitschrift fur Volkskunde journal 29559 Waxmann Verlag GMBH 7 0.20

Check complete list



Year wise Impact Factor (IF) of Current Treatment Options in Oncology

Impact Factor Table

Year Impact Factor (IF)
2021/2022Coming Soon
2020 5.036
2019 3.900
2018 3.851
2017 3.562
2016 2.820
2015 2.127
2014 2.822
2013 3.240
2012 2.422
2011 2.684
2010 2.213



Year wise Impact Score (IF) of Current Treatment Options in Oncology

Impact Score Table

Year Impact Score (IS)
2021/2022 Coming Soon
2020 4.66
2019 3.77
2018 4.06
2017 3.98
2016 3.33
2015 2.76
2014 3.59



Top Journals/Conferences in Oncology

Ca-A Cancer Journal for Clinicians
Wiley-Blackwell | United States

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Lancet Oncology, The
Lancet Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Nature Reviews Clinical Oncology
Nature Publishing Group | United Kingdom

Journal of Clinical Oncology
American Society of Clinical Oncology | United States

JAMA Oncology
American Medical Association | United States

Annals of Oncology
Elsevier Ltd. | United Kingdom

Molecular Cancer
BioMed Central Ltd. | United Kingdom

Cancer Discovery
American Association for Cancer Research Inc. | United States

See All

Top Journals/Conferences in Pharmacology (medical)

Drug Resistance Updates
Churchill Livingstone | United States

Pharmacology and Therapeutics
Elsevier Inc. | United States

Alimentary Pharmacology and Therapeutics
Wiley-Blackwell Publishing Ltd | United Kingdom

American Journal of Transplantation
Wiley-Blackwell Publishing Ltd | United Kingdom

npj Breast Cancer
Nature Publishing Group | United Kingdom

npj Vaccines
Nature Publishing Group | United Kingdom

Neurotherapeutics
Springer New York | United States

ACS Pharmacology and Translational Science
American Chemical Society | United States

Journal of Biomedical Science
BioMed Central Ltd. | United Kingdom

Journal of acquired immune deficiency syndromes (1999)
Lippincott Williams and Wilkins Ltd. | United States

See All